Suppr超能文献

骨肉瘤患者辅助性干扰素治疗与脑转移瘤的晚期发生

Adjuvant interferon treatment and the late development of cerebral metastases in a patient with osteosarcoma.

作者信息

Broström L A, Ingimarson S, Strander H, Söderberg G

出版信息

Acta Orthop Scand. 1980 Aug;51(4):589-94. doi: 10.3109/17453678008990847.

Abstract

A consecutive series of patients with osteocarcoma have been receiving adjuvant interferon therapy at the Karolinska Hospital in Stockholm. We report here a case of tibial chondroblastic Grade III osteosarcoma, a boy aged 17 years, who received interferon therapy for 15 months and survived more than 5 years. The first sign of tumour spread was multiple cerebral metaseases--an observation suggesting an antitumour effect of human leucocyte interferon on osteosarcoma.

摘要

在斯德哥尔摩的卡罗林斯卡医院,一系列骨肉瘤患者一直在接受辅助性干扰素治疗。我们在此报告一例17岁男孩的胫骨III级软骨母细胞性骨肉瘤病例,该男孩接受了15个月的干扰素治疗,存活超过5年。肿瘤扩散的首个迹象是多发性脑转移——这一观察结果提示人白细胞干扰素对骨肉瘤有抗肿瘤作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验